Loading clinical trials...
Loading clinical trials...
The purpose of this study is to test the effectiveness and safety of various nivolumab combinations compared to nivolumab and ipilimumab in participants with advanced kidney cancer
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bristol-Myers Squibb
NCT06616298 · Advanced Cancer
NCT05735080 · Breast Cancer, Breast Cancer Metastatic, and more
NCT04657068 · Advanced Cancer, Metastatic Cancer, and more
NCT04900818 · Solid Tumor, Advanced Cancer, and more
NCT05004116 · Advanced Cancer, Metastatic Solid Tumor
Local Institution - 0037
New Haven, Connecticut
Local Institution
Tampa, Florida
Local Institution - 0031
Augusta, Georgia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions